Global QPCR Test for Mastitis Market Size, Share, and COVID-19 Impact Analysis, Based on Type (Cow, Goat, Poultry, Bovine, Sheep, Other Farm Animals), Based on Molecular Diagnostics (Respiratory Testing, Abortion Pathogens, Mastitis Pathogens, Viral Testing, Mycoplasma Testing, Bacteria Testing), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2022 – 2032
Industry: HealthcareGlobal QPCR Test for Mastitis Market Insights Forecasts to 2032
- The QPCR Test for Mastitis Market Size was valued at USD XX Billion in 2022.
- The Market Size is Growing at a CAGR of 4.45% from 2022 to 2032
- The Worldwide QPCR Test for Mastitis Market Size is expected to reach USD XX Billion by 2032
- Asia Pacific is expected to grow the fastest during the forecast period
Get more details on this report -
The Global QPCR Test for Mastitis Market Size is Expected to reach USD XX Billion by 2032, at a CAGR of 4.45% during the forecast period 2022 to 2032.
Quantitative polymerase chain reaction (qPCR) identifies DNA from pathogens commonly associated with mastitis and has various benefits. Rapid identification of mastitis-causing pathogens (approximately 3 hours), including pathogens that cannot be grown using conventional culturing techniques; objective reporting of DNA found in milk samples; and the ability to detect non-living pathogens. The commercial qPCR kit detected Mycoplasma bovis, Mycoplasma spp., Staphylococcus aureus, coagulase-negative staphylococci (CNS), Streptococcus agalactiae, Streptococcus dysgalactiae, Streptococcus uberis, Prototheca spp., Escherichia coli, Klebsiella spp. The prevalence of specific DNA is determined by its presence or absence in samples, taking into account both sampling protocols and herds. In dairy cows, pathogens in the mammary gland cause intramammary infection, which can progress to clinical or subclinical mastitis. Pathogens that cause mastitis can be classified as contagious, environmental, or opportunistic based on their primary reservoirs and mode of transmission. Infected tissues, such as the udder, serve as the primary substrate for contagious pathogens. qPCR can also be used in milk samples treated with conventional preservatives, such as the bactericidal Bronopol (2-bromo-2-nitropropan-1,3-diol). When compared to bacterial culture, qPCR significantly reduces analysis time and enables the simultaneous testing of a large number of milk samples for a variety of pathogens.
Global QPCR Test for Mastitis Market Report Coverage
Report Coverage | Details |
---|---|
Base Year: | 2022 |
Market Size in 2022: | USD XX Billion |
Forecast Period: | 2022-2032 |
Forecast Period CAGR 2022-2032 : | 4.45% |
2032 Value Projection: | USD XX Billion |
Historical Data for: | 2018-2021 |
No. of Pages: | 200 |
Tables, Charts & Figures: | 120 |
Segments covered: | Based on Type, Based on Molecular Diagnostics and COVID-19 Impact Analysis |
Companies covered:: | Bio-Rad Laboratories, Zoetis Inc., IDEXX Laboratories, Thermo Fisher Scientific, Qiagen, Neogen Corporation, Randox Laboratories Ltd., LGC Genomics, Biomerieux SA, GE Healthcare and other Key Vendors. |
Growth Drivers: | QPCR Test for Mastitis Market Dynamics |
Pitfalls & Challenges: | COVID-19 Empact, Challenge, Future, Growth, & Analysis |
Get more details on this report -
Market Dynamics
QPCR Test for Mastitis Market Dynamics
The Global Quantitative Polymerase Chain Reaction (qPCR) Test for Mastitis Market is being propelled by several key drivers that underscore its importance in the dairy industry. Firstly, the increasing prevalence of mastitis, a common and economically significant ailment affecting dairy cows, has heightened the demand for accurate and timely diagnostic tools. The qPCR test, with its ability to swiftly identify mastitis-causing pathogens, addresses this need effectively, enabling prompt intervention and management.
Restraints & Challenges
Despite the promising growth of the Global Quantitative Polymerase Chain Reaction (qPCR) Test for Mastitis Market, certain restraints pose challenges to its expansion. Limited awareness and education among some dairy farmers regarding the benefits of qPCR testing hinder widespread adoption. Economic constraints in certain regions also impede investment in advanced diagnostic technologies. Additionally, concerns over the initial costs associated with qPCR implementation and the need for specialized training for accurate interpretation may slow down market penetration.
Regional Forecasts
North America Market Statistics
Get more details on this report -
North America is anticipated to dominate the QPCR Test for Mastitis market from 2023 to 2032. The presence of major key players who provide a wide range of treatment options for this disease, as well as an increase in animal healthcare infrastructure that is paving the way for farmers to become more aware of animal health, are also expected to contribute to market growth in the region.
Asia Pacific Market Statistics
Asia Pacific is witnessing the fastest market growth between 2023 to 2032. The market's expansion can be attributed to the region's large number of cattle, as well as the increasing cases of mastitis disease in cattle. Furthermore, the increasing number of dairy farms in this region is a key factor driving market growth over the forecast period.
Segmentation Analysis
Insights by Type
The Cow segment accounted for a significant market share over the forecast period 2023 to 2032. Cows represent a significant portion of the market, given their predominant role in the dairy industry. The QPCR test for mastitis in cows is widely adopted due to the economic impact of mastitis on milk production.
Insights by Molecular Diagnostics
The mastitis pathogens segment accounted for a significant market share over the forecast period 2023 to 2032. A fundamental segment, QPCR tests for mastitis pathogens specifically target bacteria causing mastitis in dairy animals. Early and accurate detection is vital for timely treatment and prevention of economic losses in milk production.
Major players in the market
- Bio-Rad Laboratories
- Zoetis Inc.
- IDEXX Laboratories
- Thermo Fisher Scientific
- Qiagen
- Neogen Corporation
- Randox Laboratories Ltd.
- LGC Genomics
- Biomerieux SA
- GE Healthcare
- Others
Market Segmentation
This study forecasts revenue at global, regional, and country levels from 2023 to 2032.
QPCR Test for Mastitis Market, Type Analysis
- Cow
- Goat
- Poultry
- Bovine
- Sheep
- Other Farm Animals
QPCR Test for Mastitis Market, Molecular Diagnostics Analysis
- Respiratory Testing
- Abortion Pathogens
- Mastitis Pathogens
- Viral Testing
- Mycoplasma Testing
- Bacteria Testing
QPCR Test for Mastitis Market, Regional Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- Uk
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- UAE
- Saudi Arabia
- South Africa
Need help to buy this report?